ADD drugs may cause prolonged erections

accreditation
iStock
A leading type of stimulant used to treat attention deficit disorder can cause rare cases of painful and long-lasting erections, the US Food and Drug Administration warned.

The agency, in a notice on its website, said its review documented the problem, formally known as priapism, in males 8 to 33 years of age who took drugs containing methylphenidate.

The chemical is the active ingredient of Novartis AG's Ritalin and Johnson & Johnson's Concerta.

Permanent damage

Generic forms of both drugs are also widely used. Drug labels of such products will be updated to warn of the potential but rare danger, the FDA said. "Younger males, especially those that have not yet reached puberty, may not recognize the problem or may be embarrassed to tell anyone if it occurs," the FDA said.

The agency said patients developing erections lasting more than four hours should seek immediate medical attention to prevent permanent damage to the penis.

A non-stimulant drug also used to treat attention deficit hyperactivity disorder, Eli Lilly and Co's Strattera, has also been linked to priapism in young children, teenagers and adults.

Strattera, whose chemical name is atomoxetine, appears to pose a greater risk than methylphenidate products, the FDA said. "Health care professionals should be cautious when considering changing patients from methylphenidate to atomoxetine" products, the agency said.

 

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE